Global Coatings for Medical Devices Industry

Jun 16, 2010, 12:55 ET from Reportlinker

NEW YORK, June 16 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Coatings for Medical Devices industry

http://www.reportlinker.com/p0197154/Global-Coatings-for-Medical-Devices-industry.html

This report analyzes the worldwide markets for Coatings for Medical Devices in US$ Million by the following segments: Active Coatings, Protective Coatings, Optical Coatings, and Nanotechnology Coatings. The report provides separate comprehensive analytics for North America, Europe and Rest of World. Annual estimates and forecasts are provided for each region for the period 2006 through 2015. The report profiles 83 companies including many key and niche players such as Abbott Laboratories, Inc., Accord Biomaterials, Inc., AdvanSource Biomaterials Corp, AeonClad Coatings LLC, Affinergy, Inc., Allvivo Vascular, Inc., Angiotech Pharmaceuticals, Inc., Armoloy of Connecticut, Inc., AST Products, Inc., Bacterin International Inc., Biocoat, Inc., Biophan Technologies, Inc., Carmeda AB, Ceragenix Pharmaceuticals Inc., Covalon Technologies Ltd., Hemoteq AG, Hydromer, Inc., I-Flow Corp., Implant Sciences Corp, MIV Therapeutics, Inc., Nerites Corp., Nanocopoeia, Inc., NUCRYST Pharmaceuticals Corp., Specialty Coating Systems, Inc., Spire Corp, and SurModics, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

COATINGS FOR MEDICAL DEVICES MCP-1769

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-3

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

Active Coatings I-3

Protective Coatings I-4

Optical Coatings I-4

Nanotechnology Coatings I-4

II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW II-1

Medical Devices - A Global Insight II-1

US Leads the Medical Devices Market II-1

Table 1: Worldwide Medical Devices Market by Geographic

Region: Percentage Breakdown of Value Sales for United

States, Europe, Japan and Rest of World (includes

corresponding Graph/Chart) II-1

Table 2: European Medical Device Market by Geographic Region:

Percentage Breakdown of Production for Germany, France, UK,

Italy and Rest of Europe (includes corresponding Graph/Chart) II-2

Coatings - An Indispensable Role to Play in Medical Devices II-2

Making Extraordinary Contribution to Ordinary Medical Devices II-2

Cooling the Issue of Bacterial Growth & Contamination II-3

Combating Biofilms and Hospital Acquired Infections with

Coated Medical Devices II-3

Coatings Redefine the Functionality of Medical Devices II-4

Advanced Coatings on Medical Implants II-4

Coating Medical Devices - A Powerful Approach to Control

Restenosis II-4

Multi-functional Coating - A One-for-All Approach Against

Device Induced Infection II-5

Advanced Coatings - Enhancing Lifespan of Implants II-5

Lubricious Coatings - Imparting Multiple Properties to Medical

Devices II-6

Aqueous-based Coatings Win Over Solvent-based II-6

Drug-Eluting Stent Coatings - A Breakthrough Biologic II-7

Cell Signaling DES Coatings II-7

Biodegradable DES Coatings II-7

United States - The Largest Market for Drug-Eluting Stents II-7

New Approaches to Tackle Biofilm Formation Head On II-8

Medical Companies Weighing Up the Silver Technology II-8

Cardiology - A High Potential End-Use Market II-9

Current and Future Analysis II-9

The Current Perspective II-10

Market Drivers II-10

Developing Economies II-10

Rise in Aging Population II-11

Increasing Life Expectancy Rates II-11

Rise in Incidence of Joint Diseases II-12

Table 3: Select Musculoskeletal Conditions - Percentage

Breakdown by Age Group (includes corresponding Graph/Chart) II-12

Rise in Joint Replacement Surgeries II-12

Increasing Life Expectancy Improves Rates of Revision

Procedures II-13

Rise in Hospital-Acquired Infections II-13

Drug-Eluting Stents Transform the Scenario of Interventional

Cardiology II-13

The Future Perspective II-13

2. MARKET TRENDS AND ISSUES II-15

Contamination of Intravenous Equipment: A Weighty Issue II-15

Staggering Number of Hospital Acquired Infections Ring Alarm II-15

The Battle Against Microbes Continues II-16

Lack of Awareness - An Impasse for Fast Uptake of

Antimicrobial Coated Catheters II-16

Nanotechnology Potential in Coating Yet Unexplored II-16

Nanomaterials Applications in Medical Devices II-16

Smart Coatings II-17

Suboptimal Coatings - A Prime Concern II-18

High Price - A Major Impediment to DES Growth II-18

Adverse Effects, Product Limitations Restrict Des Market Growth II-18

3. PRODUCT OVERVIEW II-20

Coating for Medical Devices - Expanding Beyond Boundaries II-20

Medical Device Coatings - By Platform II-20

Active Coatings II-20

Optical Coatings II-20

Protective Coatings II-21

Nano-based Coatings II-21

Coating and Surface Treatment Technologies II-21

Surface Adsorption II-21

Drug Sequestering II-22

Ion Beam Assisted Deposition II-22

Ion Implantation II-22

Physical Vapor Deposition II-23

Plasma Surface Modification II-23

Plasma Surface Modification Technology Applications by

Medical Specialty II-24

Ultraviolet Curing II-24

Issues Associated with Coating Technologies II-25

Medical Device Coating Materials II-25

Aluminum II-25

Aluminum Fluoride II-25

Diamond Coatings II-26

Parylene Coating II-26

Parylene HT II-26

Parylene HT Applications II-27

Silver II-27

Silver Coating Technique II-28

Silicone II-28

Titanium Dioxide II-28

TiN II-29

4. LEADING DRUG-ELUTING STENTS MARKET II-30

Big Names Corner Big Share in DES Market II-30

DES Product Launches by Major Manufacturers between 2002 and

2007 II-30

Cypher Leads the Drug-Eluting Stents Market II-30

TAXUS' the Leader in the Largest Stents Market, the US II-31

5. PRODUCT INNOVATIONS/INTRODUCTIONS/ APPROVALS II-32

Nucryst Pharmaceuticals Introduces Acticoat™ Flex7 and Flex3 II-32

Nucryst Receives FDA Marketing Clearance for Acticoat™ Flex II-32

EFD Rolls Out New Aseptic Spray Valve II-32

Boston Scientific Wins FDA Approval for Second-generation

Drug-Coated Stent II-33

Abbott Obtains FDA Approval for XIENCE V™ II-33

Lombard Medical Develops New Catheter Coating II-33

Ecology Coatings to Launch EcoQuick Product Line II-33

Bayer MaterialScience to Develop Hydrophilic PU Coatings II-33

Ceragenix Announces Pre-clinical Outcome of CeraShield Coated

Tubes II-34

Ceragenix Pharmaceuticals Introduces New Coating Compound II-34

Sono-Tek Rolls Out MediCoat PSI II-34

C.R. Bard Obtains FDA Clearance for Agento Endotracheal Tube II-34

Boston Scientific Wins Japanese Approval for TAXUS® Express2™

Stent System II-34

EFD Releases New Adhesive Coating System, Relius™ II-35

Arkansas Researchers Develop Nanowires Coating for Titanium

Implants II-35

Micell Develops Coating Technology for Safe and Effective

Medical Devices II-35

6. RECENT INDUSTRY ACTIVITY II-36

Biocoat Inks Agreement with Agion Technologies II-36

AST Products and Keller Medical Ink Agreement II-36

Nobel Biocare and Ceragenix Pharmaceuticals Sign Agreement II-36

MAST BioSurgery Inks Agreement with Ceragenix Pharmaceuticals II-36

AeonClad Coatings Establishes AeonClad Biomedical II-37

Hydromer Divests Business to Forefront Medical Technologies II-37

Lombard Medical to Divest Polymer Coatings Business II-37

Berwind Acquires Specialty Coating Systems II-37

DSM Acquires The Polymer Technology Group II-38

Curtiss-Wright Acquires Parylene Coating II-38

Wright Medical Group Acquires INBONE Technologies II-38

Biophan Acquires Nanoset's Patent Portfolio II-39

AdvanSource, the New Corporate Identity of CardioTech II-39

CardioTech Divest Subsidiary to TACPRO II-39

CardioTech Sells Gish Biomedical II-39

Covalon Technologies Signs Agreement for Antimicrobial Coating II-39

Nanocopoeia Inks Licensing Agreement with WORLDiscoveries™ II-39

Carestream Health Forms Tollcoating.com II-40

Nerites Receives SBIR Grant for Polymer Coating II-40

Affinergy Receives SBIR Grant for Polymer Coating II-40

HnG Medical and Hydromer Ink Agreement II-40

David Lu Signs Agreement with Hydromer II-41

SurModics Enters into Partnership with Elixir Medical II-41

Specialty Coating Announces Parylene Japan Acquisition II-41

MIV Therapeutics Announces Acquisition of Biosync Scientific II-41

Greatbatch Acquires Biomec Assets II-42

DSM Venturing Acquires Stake in Harland Medical Systems II-42

SurModics Collaborates with OakRiver Technology II-42

Hydromer and Allium Announce Coating Services Agreement II-42

Lombard Medical Receives Financial Assistance from Yorkshire

Forward II-42

Kane Biotech Signs Agreement with Harland Medical Systems II-43

SurModics and Paragon Collaborate to Develop New Stent System II-43

AST Products Enters into a Licensing Deal with EKOS II-43

AST Products Joins Hands with Percutaneous Systems II-43

AST Products and LeMaitre Vascular Sign Licensing Deal II-44

7. FOCUS ON SELECT GLOBAL PLAYERS II-45

Abbott Laboratories, Inc. (US) II-45

Accord Biomaterials, Inc. (US) II-45

AdvanSource Biomaterials Corp. (US) II-45

AeonClad Coatings LLC (US) II-46

Affinergy, Inc. (US) II-46

Allvivo Vascular, Inc. (US) II-46

Angiotech Pharmaceuticals, Inc. (Canada) II-46

Armoloy of Connecticut, Inc. (US) II-47

AST Products, Inc. (US) II-47

Bacterin International Inc. (US) II-48

Biocoat, Inc. (US) II-48

Biophan Technologies, Inc. (US) II-48

Carmeda AB (Sweden) II-49

Ceragenix Pharmaceuticals Inc. (US) II-49

Covalon Technologies Ltd. (Canada) II-49

Hemoteq AG (Germany) II-50

Hydromer, Inc. (US) II-50

I-Flow Corp. (US) II-50

Implant Sciences Corp. (US) II-51

MIV Therapeutics, Inc. (Canada) II-51

Nerites Corp. (US) II-51

Nanocopoeia, Inc. (US) II-51

NUCRYST Pharmaceuticals Corp. (US) II-52

Specialty Coating Systems, Inc. (US) II-52

Spire Corp. (US) II-52

SurModics, Inc. (US) II-53

8. GLOBAL MARKET PERSPECTIVE II-54

Table 4: World Recent Past, Current and Future Analysis for

Medical Device Coatings* by Geographic Region/Country - North

America, Europe and Rest of World Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2006 through 2015 (includes corresponding Graph/Chart) II-54

Table 5: World 10-Year Perspective for Medical Device

Coatings* by Geographic Region/Country - Percentage Breakdown

of Dollar Sales for North America, Europe and Rest of World

Markets for Years 2006, 2009 & 2015 (includes corresponding

Graph/Chart) II-55

Table 6: World Recent Past, Current and Future Analysis for

Active Coatings in Medical Devices by Geographic

Region/Country - North America, Europe and Rest of World

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2006 through 2015 (includes

corresponding Graph/Chart) II-56

Table 7: World 10-Year Perspective for Active Coatings in

Medical Devices by Geographic Region/Country - Percentage

Breakdown of Dollar Sales for North America, Europe and Rest

of World Markets for Years 2006, 2009 & 2015 (includes

corresponding Graph/Chart) II-57

Table 8: World Recent Past, Current and Future Analysis for

Protective Coatings in Medical Devices by Geographic

Region/Country - North America, Europe and Rest of World

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2006 through 2015 (includes

corresponding Graph/Chart) II-58

Table 9: World 10-Year Perspective for Protective Coatings in

Medical Devices by Geographic Region/Country - Percentage

Breakdown of Dollar Sales for North America, Europe and Rest

of World Markets for Years 2006, 2009 & 2015 (includes

corresponding Graph/Chart) II-59

Table 10: World Recent Past, Current and Future Analysis for

Optical Coatings in Medical Devices by Geographic

Region/Country - North America, Europe and Rest of World

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2006 through 2015 (includes

corresponding Graph/Chart) II-60

Table 11: World 10-Year Perspective for Optical Coatings in

Medical Devices by Geographic Region/Country - Percentage

Breakdown of Dollar Sales for North America, Europe and Rest

of World Markets for Years 2006, 2009 & 2015 (includes

corresponding Graph/Chart) II-61

Table 12: World Recent Past, Current and Future Analysis for

Nanotechnology Coatings in Medical Devices by Geographic

Region/Country - North America, Europe and Rest of World

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2009 through 2015 (includes

corresponding Graph/Chart) II-62

Table 13: World 7-Year Perspective for Nanotechnology Coatings

in Medical Devices by Geographic Region/Country - Percentage

Breakdown of Dollar Sales for North America, Europe and Rest

of World Markets for Years 2010 & 2015 (includes corresponding

Graph/Chart) II-63

III. MARKET

1. NORTH AMERICA III-1

A.Market Analysis III-1

Current and Future Analysis III-1

The United States Outlook III-1

Hospital-Acquired Infections - A Serious Concern in the US III-1

Drug Eluting Stents Growth Faces Roadblock III-1

DES Product Launches by Major Manufacturers between 2003

and 2007 III-2

Aging Population, Obesity Drive Demand for Orthopedic Implants III-2

Table 14: Primary Hip and Knee Replacement Procedures in

the US - Percentage Breakdown by Age Group (includes

corresponding Graph/Chart) III-2

Table 15: US Population - Percentage Proportion of

Population by Age Group (includes corresponding

Graph/Chart) III-3

Rising Incidence of Arthritis Aids Growth in Implant

Procedures III-3

Table 16: Knee Replacements in the US (1998-2008): Number

of Procedures (in Thousands) (includes corresponding

Graph/Chart) III-4

Table 17: Hip Replacements in the US (1998-2005): Number

of Procedures (in Thousands) (includes corresponding

Graph/Chart) III-4

Medicare Curtails Reimbursement for Hospital- acquired

Nosocomial Infections III-5

The Canadian Outlook III-5

Aging Population, Arthritis Fuel Demand for Knee Implants III-5

Product Innovations/Introductions/Approvals III-5

Strategic Corporate Developments III-8

Key Players III-16

B.Market Analytics III-24

Table 18: North American Recent Past, Current and Future

Analysis for Medical Device Coatings by Type - Active,

Protective, Optical and Nanotechnology Coating Platforms

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2006 through 2015 (includes corresponding

Graph/Chart) III-24

Table 19: North American 10-Year Perspective for Medical

Device Coatings by Type - Percentage Breakdown of Dollar

Sales for Active, Protective, Optical and Nanotechnology

Markets for Years 2006, 2009 & 2015 (includes corresponding

Graph/Chart) III-25

2. EUROPE III-26

A.Market Analysis III-26

Current and Future Analysis III-26

Product Innovations/Introductions/Approvals III-26

Strategic Corporate Developments III-27

Key Players III-27

B.Market Analytics III-28

Table 20: European Recent Past, Current and Future Analysis

for Medical Device Coatings by Type - Active, Protective,

Optical and Nanotechnology Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2006

through 2015 (includes corresponding Graph/Chart) III-28

Table 21: European 10-Year Perspective for Medical Device

Coatings by Type - Percentage Breakdown of Dollar Sales for

Active, Protective, Optical and Nanotechnology Markets for

Years 2006, 2009 & 2015 (includes corresponding Graph/Chart) III-29

3. REST OF WORLD III-30

A.Market Analysis III-30

Current and Future Analysis III-30

Strategic Corporate Developments III-30

B.Market Analytics III-32

Table 22: Rest of World Recent Past, Current and Future

Analysis for Medical Device Coatings by Type - Active,

Protective, Optical and Nanotechnology Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2006 through 2015 (includes corresponding Graph/Chart) III-32

Table 23: Rest of World 10-Year Perspective for Medical

Device Coatings by Type - Percentage Breakdown of Dollar

Sales for Active, Protective, Optical and Nanotechnology

Markets for Years 2006, 2009 & 2015 (includes corresponding

Graph/Chart) III-33

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 83 (including Divisions/Subsidiaries - 86)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 69

Canada 5

Europe 11

Germany 2

The United Kingdom 5

Rest of Europe 4

Asia-Pacific (Excluding Japan) 1

------------------------------------------

To order this report:

Paint and Coating Industry: Global Coatings for Medical Devices industry

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626



SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com